"As Indiana's first comprehensive cancer center, we offer world-class expertise and personalized, compassionate care. From the moment you enter our facility, you’re surrounded by a multidisciplinary team of fellowship-trained specialists, dedicated to treating a single disease. Yours. We believe in team-based care, with you at the center. We work together on your care plan, discussing every detail of your case with each other and then, with you. We’ll talk about a lot of things: timelines, treatment options and possible outcomes. But the most important thing we’ll discuss is you."

During the past decade, Goshen Center for Cancer Care conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 62 clinical trials were completed, i.e. on average, 106.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 28 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Goshen Center for Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Radiation Therapy Oncology Group" with 15 trials sponsored, "Gilead Sciences" with 12 trials sponsored, "NRG Oncology" with 11 trials sponsored and "SWOG Cancer Research Network" with 11 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Goshen Center for Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Walther Cancer Institute" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Goshen Center for Cancer Care" are "Breast Cancer" (14 trials), "Pancreatic Cancer" (9 trials), "Prostate Cancer" (7 trials), "Melanoma" (6 trials) and "Metastatic Cancer" (6 trials). Many other conditions were trialed in "Goshen Center for Cancer Care" in a lesser frequency.

Most popular intervention types in "Goshen Center for Cancer Care" are "Drug" (117 trials), "Radiation" (36 trials), "Other" (32 trials), "Biological" (26 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (12 trials), "Gemcitabine" (11 trials) and "Paclitaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Goshen Center for Cancer Care" are 114 trials for "All" genders, 17 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Goshen Center for Cancer Care". undefined are not yet recruiting, 17 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Goshen Center for Cancer Care, 2 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Goshen Center for Cancer Care, 23 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".